| | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

| | | |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| Title of each class | Trading Symbol | Name of each exchange on which registered |
| | | The |
|
4
|
||
|
4
|
||
| 8 | ||
|
18
|
||
|
23
|
||
|
24
|
||
|
24
|
||
|
24
|
||
|
25
|
||
|
25
|
||
|
June 30,
2026
|
December 31,
2025
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
| Accounts receivable-trade, net of allowance for credit losses of $ |
|
|
||||||
|
Inventory
|
|
|
||||||
|
Prepaid expenses
|
|
|
||||||
|
Other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
Property and equipment, at cost
|
|
|
||||||
|
Less accumulated depreciation
|
( |
)
|
( |
)
|
||||
|
Property and equipment, net
|
|
|
||||||
|
Operating lease assets
|
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
|
Other assets
|
|
|
||||||
|
TOTAL ASSETS
|
$
|
|
$
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Accounts payable-trade
|
$
|
|
$
|
|
||||
|
Accrued expenses and other liabilities
|
|
|
||||||
|
Income taxes payable
|
|
|
||||||
|
Current portion of operating lease liabilities
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
Uncertain tax positions
|
|
|
||||||
|
Other non-current liabilities
|
|
|
||||||
|
Operating lease liabilities, non-current
|
|
|
||||||
|
COMMITMENTS AND CONTINGENCIES (Note 7)
|
||||||||
|
STOCKHOLDERS’ EQUITY:
|
||||||||
| Common stock, $ |
|
|
||||||
|
Paid-in capital
|
|
|
||||||
|
Retained earnings
|
|
|
||||||
| Treasury stock at cost ( |
( |
) |
( |
) |
||||
|
Accumulated other comprehensive loss, net of tax
|
( |
)
|
( |
)
|
||||
|
Total stockholders’ equity
|
|
|
||||||
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
|
$
|
|
||||
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2026
|
2025
|
2026
|
2025
|
|||||||||||||
|
Net sales
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Cost of sales
|
|
|
|
|
||||||||||||
|
Gross profit
|
|
|
|
|
||||||||||||
|
Operating expenses
|
|
|
|
|
||||||||||||
|
Income from operations
|
|
|
|
|
||||||||||||
|
Other income (expense):
|
||||||||||||||||
|
Interest income
|
|
|
|
|
||||||||||||
|
Gain on disposal of headquarter
|
|
|
||||||||||||||
|
Other, net
|
( |
)
|
( |
)
|
( |
)
|
( |
)
|
||||||||
|
Total other income (loss)
|
|
( |
)
|
|
|
|||||||||||
|
Income (loss) before income taxes
|
|
( |
)
|
|
|
|||||||||||
|
Income tax provision
|
|
|
|
|
||||||||||||
|
Net income (loss)
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
|
|||||||
|
Foreign currency translation adjustments, net of tax
|
( |
)
|
|
( |
)
|
|
||||||||||
|
Comprehensive income
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Net income (loss) per common share:
|
||||||||||||||||
|
Basic
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
|
|||||||
|
Diluted
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
|
|||||||
|
Weighted average number of shares outstanding:
|
||||||||||||||||
|
Basic
|
|
|
|
|
||||||||||||
|
Diluted
|
|
|
|
|
||||||||||||
|
For the Six Months Ended June 30,
|
||||||||
|
2026
|
2025
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
|
$
|
|
||||
|
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||
|
Depreciation and amortization
|
|
|
||||||
|
Operating lease asset amortization
|
|
|
||||||
|
Gain on disposal of assets
|
|
( |
)
|
|||||
|
Stock-based compensation
|
|
|
||||||
|
Deferred income taxes
|
( |
)
|
|
|||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable-trade
|
|
( |
)
|
|||||
|
Inventory
|
( |
)
|
( |
)
|
||||
|
Prepaid expenses
|
|
( |
)
|
|||||
|
Other current assets
|
|
|
||||||
|
Accounts payable-trade
|
|
( |
)
|
|||||
|
Accrued expenses and other liabilities
|
( |
)
|
( |
)
|
||||
|
Income taxes, net
|
( |
)
|
|
|||||
|
Other assets
|
( |
)
|
( |
)
|
||||
|
Operating lease liabilities
|
( |
)
|
( |
)
|
||||
|
Total adjustments
|
( |
)
|
( |
)
|
||||
|
Net cash used in operating activities
|
( |
)
|
( |
)
|
||||
|
Cash flows from investing activities:
|
||||||||
|
Purchase of property and equipment
|
( |
)
|
( |
)
|
||||
|
Proceeds from sales of Headquarter assets, net
|
|
|
||||||
|
Net cash (used in) provided by investing activities
|
( |
)
|
|
|||||
|
Cash flows from financing activities:
|
||||||||
|
Dividend Paid
|
( |
)
|
( |
)
|
||||
|
Withholding of vested stock for employee tax
|
( |
)
|
( |
)
|
||||
|
Net cash used in financing activities
|
( |
)
|
( |
)
|
||||
|
Effect of exchange rate changes on cash and cash equivalents
|
( |
)
|
|
|||||
|
Net (decrease) increase in cash and cash equivalents
|
( |
)
|
|
|||||
|
Cash and cash equivalents, beginning of period
|
|
|
||||||
|
Cash and cash equivalents, end of period
|
$
|
|
$
|
|
||||
|
Number of
Shares Common
Stock
Outstanding
|
Par Value
|
Paid-in Capital
|
Treasury Stock
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Total
|
||||||||||||||||||||||
|
Balance, December 31, 2025
|
|
$
|
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
( |
)
|
$
|
|
|||||||||||||
|
Stock-based compensation expense
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Vesting of restricted stock units
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Repurchase of common stock
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Dividend Paid
|
-
|
|
|
|
( |
)
|
|
( |
)
|
|||||||||||||||||||
|
Withholding of vested stock for employee tax
|
( |
)
|
|
( |
)
|
|
|
|
( |
)
|
||||||||||||||||||
|
Foreign currency translation adjustments, net of tax
|
-
|
|
|
|
|
( |
)
|
( |
)
|
|||||||||||||||||||
|
Balance, March 31, 2026
|
|
$
|
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
( |
)
|
$
|
|
|||||||||||||
|
Stock-based compensation expense
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Vesting of restricted stock units
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Repurchase of common stock
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Dividend Paid
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Withholding of vested stock for employee tax
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Foreign currency translation adjustments, net of tax
|
-
|
|
|
|
|
( |
)
|
( |
)
|
|||||||||||||||||||
|
Balance, June 30, 2026
|
|
|
|
( |
)
|
|
( |
)
|
|
|||||||||||||||||||
|
Balance, December 31, 2024
|
|
$
|
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
( |
)
|
|
||||||||||||||
|
Stock-based compensation expense
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Vesting of restricted stock units
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Dividend Paid
|
-
|
|
|
|
( |
)
|
|
( |
)
|
|||||||||||||||||||
|
Foreign currency translation adjustments, net of tax
|
-
|
|
|
|
|
( |
)
|
( |
)
|
|||||||||||||||||||
|
Balance, March 31, 2025
|
|
$
|
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
( |
)
|
$
|
|
|||||||||||||
|
Stock-based compensation expense
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Vesting of restricted stock units
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Repurchase of common stock
|
( |
)
|
|
( |
)
|
|
|
|
( |
)
|
||||||||||||||||||
|
Net loss
|
-
|
|
|
|
( |
)
|
|
( |
)
|
|||||||||||||||||||
|
Dividend Paid
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Foreign currency translation adjustments, net of tax
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Balance, June 30, 2025
|
|
|
|
( |
)
|
|
( |
)
|
|
|||||||||||||||||||
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
(in thousands)
|
2026
|
2025
|
2026
|
2025
|
||||||||||||
|
United States
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Canada
|
|
|
|
|
||||||||||||
|
Other
|
|
|
|
|
||||||||||||
|
Net sales
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
(in thousands)
|
June 30, 2026
|
December 31, 2025
|
||||||
|
On hand:
|
||||||||
|
Finished goods held for sale
|
$
|
|
$
|
|
||||
|
Raw materials and work in process
|
|
|
||||||
|
Inventory in transit
|
|
|
||||||
|
TOTAL
|
$
|
|
$
|
|
||||
| ● |
Level 1 – observable inputs that reflect quoted prices in active markets for identical assets or liabilities.
|
| ● |
Level 2 – significant observable inputs other than quoted prices in active markets for similar assets and liabilities, such as quoted prices for identical or similar assets or liabilities in markets that are
not active; or other inputs that are observable or can be corroborated by observable market data.
|
| ● |
Level 3 – significant unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made by other market participants.
|
|
Shares
(in thousands)
|
Weighted
Average
Share Price
|
|||||||
|
Balance, January 1, 2026
|
|
$
|
|
|||||
|
Granted
|
|
|
||||||
|
Forfeited
|
( |
)
|
|
|||||
|
Vested
|
( |
)
|
|
|||||
|
Balance, June 30, 2026
|
|
$
|
|
|||||
|
Unrecognized Expense
|
||||
|
2026
|
|
|||
|
2027
|
|
|||
|
$
|
|
|||
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
(in thousands, except share data)
|
2026
|
2025
|
2026
|
2025
|
||||||||||||
|
Numerator:
|
||||||||||||||||
|
Net income (loss)
|
$
|
|
$
|
( |
)
|
$
|
|
$
|
|
|||||||
|
Denominator:
|
||||||||||||||||
|
Basic weighted-average common shares outstanding
|
|
|
|
|
||||||||||||
|
Dilutive effect of service-based restricted stock awards granted to Board of Directors under the Plan
|
|
|
|
|
||||||||||||
|
Dilutive effect of service-based restricted stock awards granted to employees under the Plan
|
|
|
|
|
||||||||||||
|
Diluted weighted-average common shares outstanding
|
|
|
|
|
||||||||||||
|
Basic earnings per share
|
|
( |
)
|
|
|
|||||||||||
|
Diluted earnings per share
|
|
( |
)
|
|
|
|||||||||||
|
Sales and Disposal of Headquarters (in thousands)
|
||||
|
Net Proceeds
|
$
|
|
||
|
NBV of Headquarters Assets
|
|
|||
|
Net Gain
|
$
|
|
||
| Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
|
Three Months Ended June 30,
|
||||||||||||||||
|
(in thousands)
|
2026
|
2025
|
$ Change
|
% Change
|
||||||||||||
|
Sales
|
$
|
18,044
|
$
|
17,773
|
$
|
271
|
1.5
|
%
|
||||||||
|
Gross profit
|
11,695
|
10,573
|
1,122
|
10.6
|
%
|
|||||||||||
|
Gross margin percentage
|
64.8
|
%
|
59.5
|
%
|
5.3
|
%
|
||||||||||
|
Operating expenses
|
11,152
|
10,507
|
645
|
6.1
|
%
|
|||||||||||
|
Income from operations
|
$
|
543
|
$
|
66
|
$
|
477
|
722.9
|
%
|
||||||||
|
Six Months Ended June 30,
|
||||||||||||||||
|
(in thousands)
|
2026
|
2025
|
$ Change
|
% Change
|
||||||||||||
|
Sales
|
$
|
37,696
|
$
|
36,809
|
$
|
887
|
2.4
|
%
|
||||||||
|
Gross profit
|
23,688
|
21,291
|
2,397
|
11.3
|
%
|
|||||||||||
|
Gross margin percentage
|
62.8
|
%
|
57.8
|
%
|
5.0
|
%
|
||||||||||
|
Operating expenses
|
22,780
|
20,963
|
1,817
|
8.7
|
%
|
|||||||||||
|
Income from operations
|
$
|
908
|
$
|
328
|
$
|
580
|
176.8
|
%
|
||||||||
|
(amounts in thousands)
|
2026
|
2025
|
||||||
|
Net cash used in operating activities
|
$
|
(2,365
|
)
|
$
|
(4,142
|
)
|
||
|
Net cash (used in) provided by investing activities
|
(1,002
|
)
|
19,881
|
|||||
|
Net cash used in financing activities
|
(6,192
|
)
|
(12,921
|
)
|
||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(91
|
)
|
330
|
|||||
|
Net (decrease) increase in cash and cash equivalents
|
$
|
(9,650
|
)
|
$
|
3,148
|
|||
| Item 1. |
Legal Proceedings.
|
| Item 1A. |
Risk Factors.
|
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds.
|
|
ISSUER PURCHASES OF EQUITY SECURITIES
|
||||||||||||||||
|
Period
|
(a) Total
number of
shares
purchased
|
(b) Average
price paid
per share
|
(c) Total number of shares
purchased as part of publicly
announced plans or
programs
|
(d) Maximum value of shares
that may yet be purchased
under the plans or programs
|
||||||||||||
|
April 1 – April 30, 2026
|
—
|
—
|
—
|
$
|
5,000,000
|
|||||||||||
|
May 1 – May 31, 2026
|
—
|
—
|
—
|
$
|
5,000,000
|
|||||||||||
|
June 1 – June 30, 2026
|
—
|
— | — |
$
|
5,000,000
|
|||||||||||
|
Total
|
—
|
—
|
—
|
|||||||||||||
|
Exhibit
Number
|
Description
|
|
3.1
|
|
|
3.2
|
|
|
3.3
|
|
|
3.4
|
|
|
4.1
|
|
|
10.1
|
|
19.1
|
|
|
21.1
|
|
|
13a-14(a) or 15d-14(a) Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended.
|
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
*101.INS
|
XBRL Instance Document.
|
|
*101.SCH
|
XBRL Taxonomy Extension Schema Document.
|
|
*101.CAL
|
XBRL Taxonomy Extension Calculation Document.
|
|
*101.DEF
|
XBRL Taxonomy Extension Definition Document.
|
|
*101.LAB
|
XBRL Taxonomy Extension Labels Document.
|
|
*101.PRE
|
XBRL Taxonomy Extension Presentation Document.
|
|
TANDY LEATHER FACTORY, INC.
|
||
|
(Registrant)
|
|
Date: August 11, 2026
|
By:
|
/s/ Johan Hedberg
|
|
Johan Hedberg
|
||
|
Chief Executive Officer
|
||
|
(principal executive officer and principal financial officer)
|